BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29203441)

  • 1. Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer.
    Zhang MG; Lee JY; Gallo RA; Tao W; Tse D; Doddapaneni R; Pelaez D
    Pharmacol Res; 2018 Mar; 129():365-374. PubMed ID: 29203441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of oncogenic transcription factors by bioactive natural products in breast cancer.
    Hasanpourghadi M; Pandurangan AK; Mustafa MR
    Pharmacol Res; 2018 Feb; 128():376-388. PubMed ID: 28923544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital retinoblastoma: An update.
    Honavar SG; Manjandavida FP; Reddy VAP
    Indian J Ophthalmol; 2017 Jun; 65(6):435-442. PubMed ID: 28643706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progresses of DNA methylation in common ocular tumor].
    Liu X; Zhou P; Lu Y; Luo Y
    Zhonghua Yan Ke Za Zhi; 2015 Dec; 51(12):950-4. PubMed ID: 26888278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining techniques of intraocular tumors.
    Kochavi O; Munichor M; Lichtig C; Meyer E
    Ann Ophthalmol; 1992 Sep; 24(9):347-51. PubMed ID: 1471823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment of lacrimal gland carcinoma.
    Woo KI; Kim YD; Sa HS; Esmaeli B
    Curr Opin Ophthalmol; 2016 Sep; 27(5):449-56. PubMed ID: 27273588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds.
    Shanmugam MK; Lee JH; Chai EZ; Kanchi MM; Kar S; Arfuso F; Dharmarajan A; Kumar AP; Ramar PS; Looi CY; Mustafa MR; Tergaonkar V; Bishayee A; Ahn KS; Sethi G
    Semin Cancer Biol; 2016 Oct; 40-41():35-47. PubMed ID: 27038646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the novel role of pRB in eye cancer.
    Lai H; Ma F; Lai S
    J Cell Biochem; 2003 Jan; 88(1):121-7. PubMed ID: 12461781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.
    Kvanta A; Steen B; Seregard S
    Exp Eye Res; 1996 Nov; 63(5):511-8. PubMed ID: 8994354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.
    Han J; Kim YD; Woo KI; Sobti D
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
    Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gene transcription by natural products--a viable anticancer strategy.
    D'Incalci M; Brunelli D; Marangon E; Simone M; Tavecchio M; Gescher A; Mantovani R
    Curr Pharm Des; 2007; 13(27):2744-50. PubMed ID: 17897020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of melanoma tumor suppressor miRNA-124a.
    Jazirehi AR; Torres-Collado AX; Nazarian R
    Epigenomics; 2013 Jun; 5(3):251-52. PubMed ID: 24303550
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural compounds and combination therapy in colorectal cancer treatment.
    Rejhová A; Opattová A; Čumová A; Slíva D; Vodička P
    Eur J Med Chem; 2018 Jan; 144():582-594. PubMed ID: 29289883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE RADIOLOGICAL THERAPY OF PRIMARY ENDO-ORBITAL MALIGNANT TUMORS].
    BANFI A; D AMICO P
    Radiol Med; 1963 Oct; 49():834-47. PubMed ID: 14094723
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy.
    Rajagopal C; Lankadasari MB; Aranjani JM; Harikumar KB
    Pharmacol Res; 2018 Apr; 130():273-291. PubMed ID: 29305909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma.
    Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A
    Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural products from aquatic eukaryotic microorganisms for cancer therapy: Perspectives on anti-tumour properties of ciliate bioactive molecules.
    Catalani E; Proietti Serafini F; Zecchini S; Picchietti S; Fausto AM; Marcantoni E; Buonanno F; Ortenzi C; Perrotta C; Cervia D
    Pharmacol Res; 2016 Nov; 113(Pt A):409-420. PubMed ID: 27650755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis.
    Baumgart S; Ellenrieder V; Fernandez-Zapico ME
    Gut; 2013 Feb; 62(2):310-6. PubMed ID: 21997559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.